ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

We hypothesized that circulating tumor DNA (ctDNA) molecular residual disease (MRD) analysis without prior mutational knowledge could be performed after neoadjuvant chemotherapy to assess oligometastatic colorectal cancer (CRC) treated surgically with curative intent. We also investigated urine as a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JCO Precis Oncol
Autori principali: Pellini, Bruna, Pejovic, Nadja, Feng, Wenjia, Earland, Noah, Harris, Peter K., Usmani, Abul, Szymanski, Jeffrey J., Qaium, Faridi, Mudd, Jacqueline, Petty, Marvin, Jiang, Yuqiu, Singh, Ashla, Maher, Christopher A., Henke, Lauren E., Park, Haeseong, Ciorba, Matthew A., Kim, Hyun, Mutch, Matthew G., Pedersen, Katrina S., Tan, Benjamin R., Hawkins, William G., Fields, Ryan C., Chaudhuri, Aadel A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2021
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232837/
https://ncbi.nlm.nih.gov/pubmed/34250420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00276
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi